Stockholm - Delayed Quote SEK

SpectraCure AB (publ) (SPEC.ST)

0.3420
-0.0100
(-2.84%)
At close: June 13 at 5:13:18 PM GMT+2
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Cost of Revenue
-9,766
-9,766
-9,541
-3,046
-1,385
Gross Profit
9,766
9,766
9,541
3,046
1,385
Operating Expense
32,821
33,569
32,375
29,997
26,586
Operating Income
-23,055
-23,803
-22,834
-26,951
-25,201
Net Non Operating Interest Income Expense
741
739
1,425
355
-29
Pretax Income
-23,011
-23,011
-20,462
-25,379
-23,346
Tax Provision
-7
-7
-21
0
-5
Net Income Common Stockholders
-23,004
-23,004
-20,441
-25,379
-23,341
Diluted NI Available to Com Stockholders
-23,004
-23,004
-20,441
-25,379
-23,341
Basic EPS
-0.11
-0.24
-0.09
-0.11
-0.10
Diluted EPS
-0.11
-0.24
-0.09
-0.11
-0.10
Basic Average Shares
228,369.5790
97,131.6080
228,369.5790
228,369.5790
228,369.5790
Diluted Average Shares
228,369.5790
97,131.6080
228,369.5790
228,369.5790
228,369.5790
Total Operating Income as Reported
-23,057
-23,056
-21,351
-25,734
-23,317
Total Expenses
23,055
23,803
22,834
26,951
25,201
Net Income from Continuing & Discontinued Operation
-23,004
-23,004
-20,441
-25,379
-23,341
Normalized Income
-23,004
-23,004
-20,564
-25,394
-23,350
Interest Income
1,209
1,207
1,947
537
216
Interest Expense
468
468
522
182
245
Net Interest Income
741
739
1,425
355
-29
EBIT
-22,543
-22,543
-19,940
-25,197
-23,101
EBITDA
-19,908
-19,908
-17,278
-22,265
-20,434
Reconciled Cost of Revenue
-9,766
-9,766
-9,541
-3,046
-1,385
Reconciled Depreciation
2,635
2,635
2,662
2,932
2,667
Net Income from Continuing Operation Net Minority Interest
-23,004
-23,004
-20,441
-25,379
-23,341
Total Unusual Items Excluding Goodwill
--
0
123
15
9
Total Unusual Items
--
0
123
15
9
Normalized EBITDA
-19,908
-19,908
-17,401
-22,280
-20,443
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 7/1/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

3F8.BE Q-linea AB
0.0103
-0.96%
 
3F8.F Q-linea AB (publ)
0.0001
0.00%
 
ZENI.ST Zenicor Medical Systems AB
2.5600
+1.59%
 
VSD-B.ST VibroSense Dynamics AB ser. B
1.9200
-4.00%
 
ACARIX.ST Acarix AB (publ)
0.2390
+0.42%
 
QLINEA.ST Q-linea AB (publ)
0.0454
-2.78%
 
SEZI.ST Senzime AB (publ)
4.9500
-2.37%
 
BICO.ST BICO Group AB (publ)
33.14
-3.38%
 
MXCT MaxCyte, Inc.
2.2000
-3.08%
 
VNRX VolitionRx Limited
0.6358
+6.67%